Transaction Asset. The Company will submit the opinion of the Independent Financial Advisor to the shareholders for consideration together with the invitation to the Extraordinary General Meeting of

-district, Hokkaido Province, Japan per following details: 1.1 Date of Transaction Expected to be completed within February 2018 1.2 Contract Parties Seller: Pace Development Corporation Public Company

directors in sum of 14.16 million baht with interest of 6.25% per year. The company has implemented the basis of related transaction. The related transaction is to provide financial aid to the company. Based

important essence as follows: Operating Result Company’s Financial Statement in the Quarter 3/2019 has net profit amount to Baht 10.85 million or Baht 0.62 per share (2018 : at Baht 1.25 per share) compared

Relationship between waivers Share held by its subsidiaries and directors 3. General information of transaction Type and size of transaction : A waiver of the rights to purchase ordinary shares. Criteria for

share (2019 : net loss at Baht 0.35 per share) which net loss decreased by Baht 1.56 million compared to the net loss of Baht 6.21 million in the Quarter 1/2019. Our book value per share as at 31 March

purchase price is in the amount of EUR 24.7 million (or approximately Baht 890,489,3401). The details of which are as follows: 1) Transaction Date The Purchaser and Seller had entered into the Shares Sale

the debt to equity conversion scheme constituting a connected transaction and a waiver from the 1 1 preferred share has 1 voting right 4 requirement to make the tender offer for all securities of the

Type 2 Transaction (List 1). DOD Biotech Public Company Limited (the “Company”) hereby notifies the significant resolutions passed by the Board of Directors’ Meeting No. 8/2018, held on December 19, 2018

person as following details: Borrower Mana Patanakarn Company Limited as a subsidiary of Nawarat Patanakarn Public Company Limited which 100% share holding Lender 1. K Alliance Company Limited 2. Mrs